Clinical trial
Relationship Between Apelin and New-onset Atrial Fibrillation After Coronary Artery Bypass Grafting: a Prospective Cohort Study and Retrospective Case-Control Clinical Trial
NCT02807532 is registered in ClinicalTrials.gov with General Hospital of Shenyang Military Region as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relationship Between Apelin and New-onset Atrial Fibrillation After Coronary Artery Bypass Grafting: a Prospective Cohort Study and Retrospective Case-Control Clinical Trial
- Lead sponsor
- General Hospital of Shenyang Military Region
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2015
- Completion date
- June 30, 2015
- Enrollment
- 120 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
coronary atherosclerotic heart disease